CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $632 | -6.1% | 37,623 | -34.7% | 0.01% | -28.6% |
| Q3 2023 | $673 | +216.0% | 57,626 | +262.9% | 0.01% | +250.0% |
| Q2 2023 | $213 | -94.2% | 15,879 | -92.9% | 0.00% | -95.6% |
| Q1 2023 | $3,683 | +480.9% | 222,178 | +551.5% | 0.04% | +400.0% |
| Q4 2022 | $634 | -99.9% | 34,105 | +2.7% | 0.01% | +80.0% |
| Q3 2022 | $426,000 | -67.7% | 33,217 | -82.3% | 0.01% | -64.3% |
| Q2 2022 | $1,318,000 | +47.1% | 188,119 | +42.1% | 0.01% | +180.0% |
| Q4 2021 | $896,000 | +409.1% | 132,366 | +296.5% | 0.01% | +400.0% |
| Q3 2021 | $176,000 | -51.5% | 33,380 | -69.3% | 0.00% | -85.7% |
| Q4 2020 | $363,000 | +57.8% | 108,714 | +117.9% | 0.01% | 0.0% |
| Q2 2020 | $230,000 | – | 49,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |